SCRIP: European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast
Industry leaders join Forbion’s Sander Slootweg on the SCRIP podcast to discuss the future of European biotech
Forbion Managing Partner Sander Slootweg joined Rafiq Hasan, CEO of Forbion portfolio company Complement Therapeutics, and Tim Van Hauwermeiren, co-founder of argenx, for a Scrip podcast hosted by Andrew McConaghie. The discussion explored the opportunities and challenges facing Europe's biotech sector, from improving access to growth capital and creating more competitive market conditions to strengthening the region's ability to build the next generation of global life sciences companies.
The conversation also highlights the newly launched European Life Sciences Coalition (ELSC) and its mission to advocate for stronger financing, streamlined regulation and policies that enable European biotech companies to scale and compete globally.
The podcast is available to listen to on Spotify or via the SCRIP website.